Skip to main content

Table 2 Unadjusted mortality at 30 days, 5 years and 10 years stratified by RHD or non-RHD valve surgery

From: A review of outcome following valve surgery for rheumatic heart disease in Australia

Mortality number (%, 95 % CI)

All valve surgery

RHD valve surgery

Non-RHD valve surgery

RR* (95 % CI) (p value)

30 day

576/13866(4.2, 3.8 – 4.5)

35/1137(3.1, 2.2 – 4.3)

541/12729(4.3, 3.9 – 4.6)

1.38 (0.99 – 1.93)(0.058)

5 year

665/3821(17.4, 16.2 – 18.6)

54/353(15.3, 11.7 – 19.5)

611/3468(17.6, 16.4 – 18.9)

1.15 (0.89 – 1.49)(0.273)

10 year

96/254(37.8, 31.8 – 44.1)

7/28(25.0, 10.7 – 44.9)

89/226(39.4, 33.0 – 46.1)

1.58 (0.81 – 3.05)(0.139)

  1. *RR - Relative risk in RHD-related valve surgery patients compared with non-RHD surgery